Citius Pharmaceuticals, Inc. short interest in 2025
In 2025, Citius Pharmaceuticals, Inc.'s disclosed short interest ran from 7.60% of shares outstanding on 15 Jan 2025 to 15.25% on 31 Dec 2025, a change of +7.65 percentage points. The year's high was 15.45% on 15 Dec 2025 and its low 3.87% on 15 Aug 2025, averaging 9.12% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.54 days on 14 Mar 2025. Full history: Citius Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 7.60% (15 Jan 2025)
- End of year
- 15.25% (31 Dec 2025)
- Change
- +7.65 pp
- High
- 15.45% (15 Dec 2025)
- Low
- 3.87% (15 Aug 2025)
- Average
- 9.12%
- Highest days to cover
- 7.54 (14 Mar 2025)
- SEC filings marked
- 7
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 7.60% | 4.26 | |
| 31 Jan 2025 | 6.65% | 5.44 | |
| 14 Feb 2025 | 6.99% | 7.45 | 10-Q filed |
| 28 Feb 2025 | 7.08% | 1.81 | |
| 14 Mar 2025 | 6.70% | 7.54 | |
| 31 Mar 2025 | 8.82% | 1.00 | |
| 15 Apr 2025 | 9.78% | 3.33 | |
| 30 Apr 2025 | 8.68% | 4.86 | |
| 15 May 2025 | 5.86% | 4.13 | 10-Q filed, results (8-K) |
| 30 May 2025 | 6.46% | 4.79 | |
| 13 Jun 2025 | 13.10% | 1.00 | |
| 30 Jun 2025 | 9.42% | 1.00 | |
| 15 Jul 2025 | 10.90% | 1.00 | |
| 31 Jul 2025 | 7.48% | 1.50 | |
| 15 Aug 2025 | 3.87% | 3.14 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 4.67% | 1.17 | |
| 15 Sep 2025 | 6.08% | 3.83 | |
| 30 Sep 2025 | 5.75% | 3.41 | |
| 15 Oct 2025 | 9.30% | 2.76 | |
| 31 Oct 2025 | 15.17% | 1.19 | |
| 14 Nov 2025 | 13.75% | 5.59 | |
| 28 Nov 2025 | 14.10% | 3.15 | |
| 15 Dec 2025 | 15.45% | 7.10 | |
| 31 Dec 2025 | 15.25% | 1.24 | 10-K filed, results (8-K) |
See also: Citius Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.